April 15, 2026 · Form 4 insider transaction
Booth Bruce sold 2,200 shares of Kymera Therapeutics, Inc. at $89.95 per share, a transaction worth $197.9K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 16, 2025.; The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $89.95 to $90.00 inclusive.